会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • Novel polyphosphate:amp phosphotransferase
    • 新型多磷酸盐:amp磷酸转移酶
    • US20060088918A1
    • 2006-04-27
    • US10514726
    • 2003-05-28
    • Toshikazu ShibaToshitada Noguchi
    • Toshikazu ShibaToshitada Noguchi
    • C12P19/30C12N9/12
    • C12N9/1229C12N9/12C12P19/30C12P19/32C12P19/40
    • This invention relates to a novel polyphosphate: AMP phosphotransferase (PAP), a gene coding this PAP, and their use. The PAP has the following properties: (A) action: catalyzing of the following two reactions: NMP+PolyP(n)→NDP+PolyP(n-1) dNMP+POlyP(n)→dNDP+PolyP(n-1) (wherein NMP represents nucleoside monophosphate, NDP represents nucleoside diphosphate, dNMP represents deoxynucleoside monophosphate, dNDP represents deoxynucleoside diphosphate, n represents degree of polymerization of the polyphosphate which is an integer of up to 100); (B) substrate specificity: specific to AMP, GMP, IMP, dAMP, and dGMP, also acting with CMP, UMP, dCMP, and TMP; (C) molecular weight: about 55 to 56 Kd (kilodalton); and (D) specific activity: at least 70 units per 1 mg of enzyme protein,
    • 本发明涉及新型多磷酸盐:AMP磷酸转移酶(PAP),编码该PAP的基因及其用途。 PAP具有以下性质:(A)作用:催化以下两个反应:<?in-line-formula description =“In-line Formulas”end =“lead”?> NMP + PolyP(n) - > NDP + PolyP(n-1) <?in-line-formula description =“In-line Formulas”end =“tail”?> <?in-line-formula description =“In-Line Formulas”end =“lead”?> dNMP + POlyP(n) - > dNDP + PolyP(n-1) (其中NMP表示核苷单磷酸,NDP表示核苷二磷酸,dNMP表示脱氧核苷单磷酸,dNDP表示脱氧核苷二磷酸,n表示多磷酸酯的聚合度, 整数高达100); (B)底物特异性:特异于AMP,GMP,IMP,dAMP和dGMP,也与CMP,UMP,dCMP和TMP起作用; (C)分子量:约55至56Kd(千道尔顿); 和(D)比活性:每1mg酶蛋白至少70个单位,
    • 3. 发明申请
    • NOVEL POLYPHOSPHATE: AMP PHOSPHOTRANSFERASE
    • 新型聚磷酸酯:AMP磷酸酯酶
    • US20080108111A1
    • 2008-05-08
    • US11875268
    • 2007-10-19
    • Toshikazu SHIBAToshitada Noguchi
    • Toshikazu SHIBAToshitada Noguchi
    • C12P19/30
    • C12N9/1229C12N9/12C12P19/30C12P19/32C12P19/40
    • This invention relates to a novel polyphosphate: AMP phosphotransferase (PAP), a gene coding this PAP, and their use. The PAP has the following properties: (A) action: catalyzing of the following two reactions: NMP+PolyP(n)→NDP+PolyP(n-1) dNMP+PolyP(n)→dNDP+PolyP(n-1) (wherein NMP represents nucleoside monophosphate, NDP represents nucleoside diphosphate, dNMP represents deoxynucleoside monophosphate, dNDP represents deoxynucleoside diphosphate, n represents degree of polymerization of the polyphosphate which is an integer of up to 100); (B) substrate specificity: specific to AMP, GMP, IMP, dAMP, and dGMP, also acting with CMP, UMP, dCMP, and TMP; (C) molecular weight: about 55 to 56 Kd (kilodalton); and (D) specific activity: at least 70 units per 1 mg of enzyme protein,
    • 本发明涉及新型多磷酸盐:AMP磷酸转移酶(PAP),编码该PAP的基因及其用途。 PAP具有以下性质:(A)作用:催化以下两个反应:<?in-line-formula description =“In-line Formulas”end =“lead”?> NMP + PolyP(n) - > NDP + PolyP(n-1) <?in-line-formula description =“In-line Formulas”end =“tail”?> <?in-line-formula description =“In-line Formulas”end =“lead”?> dNMP + PolyP(n) - > dNDP + PolyP(n-1)
    • 4. 发明授权
    • Polyphosphate:AMP phosphotransferase
    • 多磷酸盐:AMP磷酸转移酶
    • US07329522B2
    • 2008-02-12
    • US10514726
    • 2003-05-28
    • Toshikazu ShibaToshitada Noguchi
    • Toshikazu ShibaToshitada Noguchi
    • C12N9/12C12N1/20C12P19/30C12P21/06C07H21/04
    • C12N9/1229C12N9/12C12P19/30C12P19/32C12P19/40
    • This invention relates to a novel polyphosphate: AMP phosphotransferase (PAP), a gene coding this PAP, and their use. The PAP has the following properties:(A) action: catalyzing of the following two reactions: NMP+PolyP(n)→NDP+PolyP(n-1) dNMP+POlyP(n)→dNDP+PolyP(n-1) (wherein NMP represents nucleoside monophosphate, NDP represents nucleoside diphosphate, dNMP represents deoxynucleoside monophosphate, dNDP represents deoxynucleoside diphosphate, n represents degree of polymerization of the polyphosphate which is an integer of up to 100); (B) substrate specificity: specific to AMP, GMP, IMP, dAMP, and dGMP, also acting with CMP, UMP, dCMP, and TMP;(C) molecular weight: about 55 to 56 Kd (kilodalton); and(D) specific activity: at least 70 units per 1 mg of enzyme protein.
    • 本发明涉及新型多磷酸盐:AMP磷酸转移酶(PAP),编码该PAP的基因及其用途。 PAP具有以下性质:(A)作用:催化以下两个反应:<?in-line-formula description =“In-line Formulas”end =“lead”?> NMP + PolyP(n) - > NDP + PolyP(n-1) <?in-line-formula description =“In-line Formulas”end =“tail”?> <?in-line-formula description =“In-Line Formulas”end =“lead”?> dNMP + POlyP(n) - > dNDP + PolyP(n-1) (其中NMP表示核苷单磷酸,NDP表示核苷二磷酸,dNMP表示脱氧核苷单磷酸,dNDP表示脱氧核苷二磷酸,n表示多磷酸酯的聚合度, 整数高达100); (B)底物特异性:特异于AMP,GMP,IMP,dAMP和dGMP,也与CMP,UMP,dCMP和TMP起作用; (C)分子量:约55至56Kd(千道尔顿); 和(D)比活性:每1mg酶蛋白至少70个单位。
    • 6. 发明申请
    • SUGAR CHAIN CONTAINING 4-POSITION HALOGENATED GALACTOSE AND APPLICATION THEREOF
    • 含有4-位羟基糖的糖链及其应用
    • US20090018327A1
    • 2009-01-15
    • US11815329
    • 2006-02-14
    • Shin-Ichiro NishimuraNoriko NagahoriTomoki HamamotoKiyoshi OkuyamaToshitada Noguchi
    • Shin-Ichiro NishimuraNoriko NagahoriTomoki HamamotoKiyoshi OkuyamaToshitada Noguchi
    • C07H5/02C12P19/30
    • C12P19/32C07H15/08
    • The present invention is directed to, for example, an oligosaccharide having at an end thereof a 4-position halogenated galactose residue represented by formula (I): (wherein X represents a halogen atom, and R represents a monosaccharide, an oligosaccharide, or a carrier), a transferase inhibitor containing the oligosaccharide, and a method for inhibiting sugar chain elongation reaction in the presence of glycosyltransferase, the method including employing the inhibitor.The invention also provides a method for producing a 4-position halogenated galactose sugar nucleotide represented by formula (II): (wherein each of R1 to R3 represents a hydroxyl group, an acetyl group, a halogen atom, or a hydrogen atom; X represents a halogen atom; and M represents a hydrogen ion or a metal ion), wherein the method employs bacterium-derived galactokinase and bacterium-derived hexose-1-phosphate uridylyltransferase.The invention is also directed to a sugar chain containing 4-position halogenated galactose envisaged to be employed as drugs and other materials, and to applications of the compound.
    • 本发明涉及例如末端具有由式(I)表示的4-位卤代半乳糖残基的寡糖:(其中,X表示卤素原子,R表示单糖,寡糖,或 载体),含有寡糖的转移酶抑制剂,以及在糖基转移酶存在下抑制糖链延长反应的方法,该方法包括使用该抑制剂。 本发明还提供了由式(II)表示的4-位卤代半乳糖糖核苷酸的制备方法:(式中,R 1〜R 3各自表示羟基,乙酰基,卤素原子或氢原子; X表示 卤素原子; M表示氢离子或金属离子),其中该方法采用细菌来源的半乳糖激酶和细菌来源的己糖-1-磷酸尿苷酰转移酶。 本发明还涉及设想用作药物和其它材料的4-位卤代半乳糖的糖链以及该化合物的应用。
    • 10. 发明授权
    • Sugar chain containing 4-position halogenated galactose and application thereof
    • 含有4-位卤代半乳糖的糖链及其应用
    • US08148112B2
    • 2012-04-03
    • US11815329
    • 2006-02-14
    • Shin-Ichiro NishimuraNoriko NagahoriTomoki HamamotoKiyoshi OkuyamaToshitada Noguchi
    • Shin-Ichiro NishimuraNoriko NagahoriTomoki HamamotoKiyoshi OkuyamaToshitada Noguchi
    • C12P19/50C12P19/52C12P19/26C07H15/00C07H5/04C07H5/06C08B37/00
    • C12P19/32C07H15/08
    • The present invention is directed to, for example, an oligosaccharide having at an end thereof a 4-position halogenated galactose residue represented by formula (I): (wherein X represents a halogen atom, and R represents a monosaccharide, an oligosaccharide, or a carrier), a transferase inhibitor containing the oligosaccharide, and a method for inhibiting sugar chain elongation reaction in the presence of glycosyltransferase, the method including employing the inhibitor. The invention also provides a method for producing a 4-position halogenated galactose sugar nucleotide represented by formula (II): (wherein each of R1 to R3 represents a hydroxyl group, an acetyl group, a halogen atom, or a hydrogen atom; X represents a halogen atom; and M represents a hydrogen ion or a metal ion), wherein the method employs bacterium-derived galactokinase and bacterium-derived hexose-1-phosphate uridylyltransferase. The invention is also directed to a sugar chain containing 4-position halogenated galactose envisaged to be employed as drugs and other materials, and to applications of the compound.
    • 本发明涉及例如末端具有由式(I)表示的4位卤代半乳糖残基的寡糖:(其中X表示卤素原子,R表示单糖,寡糖或 载体),含有寡糖的转移酶抑制剂,以及在糖基转移酶存在下抑制糖链延长反应的方法,该方法包括使用该抑制剂。 本发明还提供了由式(II)表示的4-位卤代半乳糖糖核苷酸的制备方法:(式中,R 1〜R 3各自表示羟基,乙酰基,卤素原子或氢原子; X表示 卤素原子; M表示氢离子或金属离子),其中该方法采用细菌来源的半乳糖激酶和细菌来源的己糖-1-磷酸尿苷酰转移酶。 本发明还涉及设想用作药物和其它材料的4-位卤代半乳糖的糖链以及该化合物的应用。